The part number 150-CD25 refers to an antibody targeting the CD25 protein, specifically the alpha chain of the high-affinity interleukin-2 (IL-2) receptor. CD25 is expressed at high levels on regulatory T (Treg) cells, which play a crucial role in suppressing the immune response. Depletion of Tregs using anti-CD25 antibodies has been explored as a potential therapeutic strategy for cancer treatment, as it can enhance the effectiveness of immunotherapies by reducing the inhibitory effects of Tregs on effector T cells.
Technical Specifications
The technical specifications of the anti-CD25 antibody are not explicitly mentioned in our research. However, it is likely that the antibody is designed to bind specifically to the CD25 protein on Treg cells, allowing for targeted depletion of these cells.
Alarm/Error Codes
There are no alarm or error codes mentioned in our research related to the anti-CD25 antibody.
User Manuals
No user manuals are provided in our research for the anti-CD25 antibody.
Troubleshooting
Troubleshooting information for the anti-CD25 antibody is not available in our research.
Programming
The anti-CD25 antibody is not programmable in the classical sense. It is a biological molecule designed to bind to a specific protein, and its function is not modifiable through programming.
Installation
The anti-CD25 antibody is typically used in vitro or in vivo for research purposes, such as in preclinical studies or clinical trials. The installation process for the antibody would depend on the specific application and the protocols used in the study.
Go to product